MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

MDT

96.58

+0.4%↑

A

137.28

-0.49%↓

VEEV

224.99

+0.5%↑

HQY

92.37

-0.06%↓

PHR.US

16.94

+0.18%↑

Search

Stevanato Group SpA

Aperta

SettoreSettore sanitario

20.31 -1.17

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

20.18

Massimo

20.68

Metriche Chiave

By Trading Economics

Entrata

10M

49M

Vendite

23M

303M

P/E

Media del settore

34.217

78.892

EPS

0.162

Rendimento da dividendi

0.26

Margine di Profitto

16.205

Dipendenti

5,521

EBITDA

10M

73M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+30.43% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.26%

2.38%

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.1B

5.6B

Apertura precedente

21.48

Chiusura precedente

20.31

Notizie sul Sentiment di mercato

By Acuity

50%

50%

149 / 374 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

29 dic 2025, 22:03 UTC

I principali Market Mover

Mining Stocks Slip Near the End of Stellar Year

29 dic 2025, 15:57 UTC

I principali Market Mover

Praxis Shares Rise on Ulixacaltamide Breakthrough Designation

29 dic 2025, 23:43 UTC

Discorsi di Mercato

Nikkei May Decline; Yen in Focus -- Market Talk

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Operate From Singapore

29 dic 2025, 23:38 UTC

Acquisizioni, Fusioni, Takeovers

Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website

29 dic 2025, 23:37 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Integrate Manus Service Into Products

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Will Continue to Operate, Sell Manus Service

29 dic 2025, 23:36 UTC

Acquisizioni, Fusioni, Takeovers

Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products

29 dic 2025, 23:35 UTC

Acquisizioni, Fusioni, Takeovers

Manus to Join Meta Platforms

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Raise Values Kraken at US$8.65 Billion

29 dic 2025, 21:33 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Octopus Targeting Kraken Separation by Mid 2026

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses

29 dic 2025, 21:31 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin's Kraken Stake to Remain at 22.7%

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin Will Continue to Hold Its 22.7% Interest in Octopus

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Additional Interest Offsets Dilution From Raise

29 dic 2025, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Doesn't Expect Material Impact on 1H Guidance Range

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale for A$76 Million Consideration

29 dic 2025, 21:29 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Expects to Complete Property Sale in 2H of FY 2026

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken's Raise Paves Way for Separation From Octopus Energy

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors

29 dic 2025, 21:28 UTC

Acquisizioni, Fusioni, Takeovers

BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto

29 dic 2025, 21:27 UTC

Acquisizioni, Fusioni, Takeovers

Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise

29 dic 2025, 20:22 UTC

Discorsi di Mercato

Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk

29 dic 2025, 20:14 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk

29 dic 2025, 20:02 UTC

Acquisizioni, Fusioni, Takeovers

Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com

29 dic 2025, 17:36 UTC

Discorsi di Mercato

U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

30.43% in crescita

Previsioni per 12 mesi

Media 27 USD  30.43%

Alto 30 USD

Basso 24 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

2

Acquista

1

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

149 / 374 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat